scholarly journals Use of pectin in patients with diabetes mellitus type 2 in the complex treatment of the periodontal disease (report 1)

2014 ◽  
Vol 0 (3) ◽  
Author(s):  
S. V. Kosenko ◽  
I. O. Balaban ◽  
O. B. Hayoshko ◽  
O. M. Ilnytska ◽  
N. M. Yatsynovych ◽  
...  
2010 ◽  
Vol 138 (7-8) ◽  
pp. 420-424 ◽  
Author(s):  
Nikola Stojanovic ◽  
Jelena Krunic ◽  
Smiljka Cicmil ◽  
Olivera Vukotic

Introduction. As a systemic disease, diabetes mellitus may lead to several complications affecting both the quality and the length of life. While periodontal disease is one of the major oral health problems in patients with diabetes, reports of an increased risk of dental caries among diabetics are controversial. Objective. The aim of this study was to investigate oral health status in patients with diabetes mellitus type 2 in relation to metabolic control of the disease. Methods. The study included 47 randomly sampled diabetics patients, divided into two groups; those with poorly controlled diabetes (glycosylated haemoglobin - HbA1c ?9%) and those with better controlled diabetes (HbA1c<9%). All patients completed a questionnaire about their medical and oral health. Decayed, missing, and filled teeth (DMFT) and plaque index (PI), bleeding on probing (BOP), probing pocket depth (PPD) and clinical attachment loss (CAL) were recorded. Results. The patients with poorly controlled diabetes had a significantly higher number of tooth caries compared to those with better controlled diabetes (6.5?4.3 vs. 4.3?2.9; p<0.05). Of periodontal parameters, only PPD was significantly higher in the patients with poorly controlled diabetes than in those with better controlled diabetes (5.8?0.9 vs. 5.2?0.8; p<0.05). DMFT index, PI, PPD and CAL exhibited positive correlation only with patients' age. Conclusion. The study indicates that there is a relationship between poor control of diabetes and caries, and periodontal disease.


2017 ◽  
Vol 98 (3) ◽  
pp. 334-337
Author(s):  
V V Kir’yanova ◽  
N V Vorokhobina ◽  
Z Kh Makhramov

Aim. To evaluate the effectiveness of bioresonance therapy use in complex treatment of patients with diabetes mellitus type 2. Methods. The treatment scheme including bioresonance therapy is offered for patients with diabetes mellitus type 2. All 413 patients were assigned to 3 comparable groups: the study group included 198 patients, control group - 72 patients, placebo group - 143 patients. Duration of diabetes in the study group was 5.47±0.37 years, in control group - 4.03±0.46 years, in placebo group - 4.97±0.39 years. All patients were treated according to the traditional scheme of treatment of type 2 diabetes. The study group in addition to pharmacotherapy received bioresonance therapy. Control group received only drug treatment and placebo group received drug therapy and bioresonance simulation procedures. All patients were checked for glycated hemoglobin, fasting plasma glucose, blood glucose 2 hours after a meal, urine glucose, and body mass index on admission and 3 months after treatment. Results. Results of glycated hemoglobin, fasting plasma glucose, blood glucose 2 hours after a meal, urine glucose, and body mass index revealed that initially studied parameters in all three groups were high. After the bioresonance therapy in complex treatment of patients with diabetes type 2 in the study group all studied parameters were statistically significantly lower compared to control and placebo groups. Conclusion. The obtained results indicate the effectiveness of bioresonance therapy use in complex treatment of patients with diabetes mellitus type 2.


F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 7 ◽  
Author(s):  
Eduardo De la Cruz-Cano ◽  
Carlos Alfonso Tovilla-Zarate ◽  
Emilio Reyes-Ramos ◽  
Thelma Beatriz Gonzalez-Castro ◽  
Isela Juarez-Castro ◽  
...  

Background: Diabetes mellitus and depression are highly prevalent conditions throughout the world and have significant impact on health outcomes. It has been estimated that diabetes mellitus type 2 affects about 246 million people in the world; nevertheless, incidence varies among countries. There is evidence that depression is associated with a poor metabolic control in patients with type 2 diabetes mellitus that present other health problems (such as hypertension and obesity). The aim of this study protocol is to determine if obesity increases the risk for depression in patient with diabetes type 2.Methods: The analysis will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).The studies suitable for inclusion will be assessed by the Newcastle-Ottawa Scale (NOS) to determine their methodological quality. To identify the studies of interest, we will search on PubMed and EBSCO databases. We will use the following keyword combinations: "Diabetes Mellitus type 2 AND obesity AND depression", "depression AND Diabetes Mellitus type 2", "Diabetes Mellitus type 2 AND body mass index cross sectional study", "depression AND obesity cross-sectional study". Causes for exclusion will be publications that studied patients diagnosed with diabetes mellitus type 1; articles that focused on the treatment and complications of diabetes mellitus type 2; publications that have studied other clinical or psychiatric conditions (for instance, seizure disorder or history of schizophrenia, bipolar disorder, psychotic symptoms or dementia).Conclusion: The results of this study will form the basis for a better understanding of the association between obesity and depression in patients with diabetes mellitus type 2, and will allow development of prediction tools and better interventions. It is evident that several modifiable and non-modifiable risk factors play an important role in the pathogenesis of diabetes among population. Currently, evidence for the deleterious effects of diabetes mellitus type 2 are based on cross-sectional or other observational designs. Therefore, this study will have important implications for future research and public health guidance.


Sign in / Sign up

Export Citation Format

Share Document